Sequana Medical to Present at BioCapital Europe and Oppenheimer’s Annual Healthcare Conference
GHENT, Belgium, March 09, 2022 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA, the…
News
Efanesoctocog alfa met primary and key secondary endpoints in pivotal study in hemophilia A, demonstrating superiority to prior factor prophylaxis treatment
Efanesoctocog alfa met primary and key secondary endpoints in pivotal study in hemophilia A, demonstrating…
Efinix® Hires Greg Barrett as CFO Completing Executive Team to Fuel Next Phase of Company Growth
Barrett brings more than three decades of industry experience at Supermicro, Rambus, Micron and Altera…
C3.AI SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against C3.ai, Inc. – AI
NEW ORLEANS–(BUSINESS WIRE)–Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of…
Travere Prices Upsized $275 Million Convertible Senior Notes Offering
SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced…
SHAREHOLDER ALERT: Robbins LLP Reminds Investors of Class Action Against C3.ai, Inc.
SAN DIEGO–(BUSINESS WIRE)–$AI #IPO—The Class: Shareholder rights law firm Robbins LLP reminds investors that a…
Metropolitan Increases Call for Conservation With $10.5 Million Investment in Public Outreach
Campaign asks public to increase water saving as state enters third year of drought LOS…
C3.AI ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against C3.ai, Inc. and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#C3–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces…
SchoolMint to Partner with LPTFA to Renovate Historic Warehouse in Downtown Lafayette into State-of-the-Art Global Headquarters
LAFAYETTE, La.–(BUSINESS WIRE)–SchoolMint®, the leading provider of Strategic Enrollment Management and positive behavior products for…
Biomea Fusion Announces Upcoming Presentations of Preclinical Data in Diffuse Large B-Cell Lymphoma, Multiple Myeloma, and Several KRAS Mutant Solid Tumors for BMF-219 at AACR Annual Meeting 2022
Irreversible covalent menin inhibitor, BMF-219, exhibited high potency and complete growth inhibition in high-grade B-cell…
Kinnate Biopharma Inc. Announces Acceptance of Abstracts for Presentation at the American Association for Cancer Research Annual Meeting
Poster presentations to highlight data from ongoing studies of the company’s lead Pan-RAF kinase inhibitor…
Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022
Context to host webinar with AACR presenters on Wednesday, April 13, 2022, at 11 a.m….
Genocea to Present Clinical and Preclinical Data at AACR Annual Meeting
Company to present late-breaking clinical trial update for TiTAN trial of GEN-011, Genocea’s neoantigen-targeted peripheral…
7 Hills Pharma’s Clinical-stage Novel Immunostimulant 7HP349 Granted FDA Fast Track Designation for Anti-PD-1-resistant Metastatic Melanoma
HOUSTON, March 08, 2022 (GLOBE NEWSWIRE) — 7 Hills Pharma LLC (“7 Hills” or “7HP”),…
Cullinan Oncology to Present Data Demonstrating Breadth and Progress of Its Immuno-Oncology Portfolio at AACR 2022
Five abstracts selected for poster presentation at the American Association for Cancer Research (AACR) Annual…
Kura Oncology Announces Multiple Abstracts Accepted for Presentation at AACR Annual Meeting
– Presentations to highlight significant opportunities targeting farnesyl transferase inhibition – SAN DIEGO, March 08,…
Gritstone Announces Three Presentations for Tumor-Specific Neoantigen (TSNA) Oncology Programs, GRANITE and SLATE, at the 2022 AACR Annual Meeting
— Oral presentation to discuss how translational immunology data…
Adagene Announces Four Poster Presentations on Robust Preclinical Pipeline of Antibody-Based Therapeutics at Upcoming American Association for Cancer Research (AACR) Annual Meeting
– New IND-enabling programs reinforce commitment to build a deep, broad and differentiated pipeline that…
Cogent Biosciences Announces Upcoming Presentations at AACR Annual Meeting 2022
CAMBRIDGE, Mass. and BOULDER, Colo., March 08, 2022 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
Kronos Bio’s Investigational CDK9 Inhibitor KB-0742 to be Featured in Four Preclinical Poster Presentations at American Association for Cancer Research Annual Meeting 2022
Data include results from preclinical studies of KB-0742 in MYC-amplified cancers, including small-cell lung, triple-negative…